Many critical advances in research utilize techniques that combine high-resolution with high-content characterization at the single cell level. We introduce the MICS (MACSima Imaging Cyclic Staining) technology, which enables the immunofluorescent imaging of hundreds of protein targets across a single specimen at subcellular resolution. MICS is based on cycles of staining, imaging, and erasure, using photobleaching of fluorescent labels of recombinant antibodies (REAfinity Antibodies), or release of antibodies (REAlease Antibodies) or their labels (REAdye_lease Antibodies). Multimarker analysis can identify potential targets for immune therapy against solid tumors. With MICS we analysed human glioblastoma, ovarian and pancreatic carcinoma, and 16 healthy tissues, identifying the pair EPCAM/THY1 as a potential target for chimeric antigen receptor (CAR) T cell therapy for ovarian carcinoma. Using an Adapter CAR T cell approach, we show selective killing of cells only if both markers are expressed. MICS represents a new high-content microscopy methodology widely applicable for personalized medicine.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813936 | PMC |
| http://dx.doi.org/10.1038/s41598-022-05841-4 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Brain tumoroids: treatment prediction and drug development for brain tumors with fast, reproducible and easy-to-use personalized models.
Neuro Oncol
September 2024
Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, GlioME Team, Marseille, France.
Background: generation of patient avatar is critically needed in neuro-oncology for treatment prediction and preclinical therapeutic development. Our objective was to develop a fast, reproducible, low-cost and easy-to-use method of tumoroids generation and analysis, efficient for all types of brain tumors, primary and metastatic.
Methods: tumoroids were generated from 89 patients: 81 primary tumors including 77 gliomas, and 8 brain metastases.
Sopa: a technology-invariant pipeline for analyses of image-based spatial omics.
Nat Commun
June 2024
Paris-Saclay University, CentraleSupélec, Laboratory of Mathematics and Computer Science (MICS), Gif-sur-Yvette, France.
Article Synopsis
- Spatial omics data enhance the analysis of tissue structures, offering single-cell resolution insights into cellular organization, but the complexity and variety of technologies create analytical challenges.
- Sopa is introduced as a unified, efficient analysis pipeline for image-based spatial omics, supporting various technologies and optimizing key analytical tasks like segmentation and spatial analysis.
- This tool aims to simplify spatial data analysis, fostering a deeper understanding of cellular interactions and tissue organization in biological research.
Unveiling spatial complexity in solid tumor immune microenvironments through multiplexed imaging.
Front Immunol
April 2024
Department of Haematology, Oncology, Gastroenterology, Nephrology, Rheumatology, University Children's Hospital Tuebingen, Tuebingen, Germany.
Article Synopsis
- Understanding the tumor immune microenvironment (TIME) is crucial for developing better cancer therapies, and multiplexed tissue imaging is a key tool for studying this complexity.
- A comprehensive immunophenotyping panel with over 121 markers was created using advanced imaging techniques to analyze primary cancer tissues, focusing on tumor heterogeneity and immune cell interactions.
- The study revealed important findings about the interactions between immunosuppressive myeloid cells and exhausted T cells in hepatocellular carcinoma, demonstrating the value of spatial profiling in uncovering clinically relevant tumor features.
MACSima imaging cyclic staining (MICS) technology reveals combinatorial target pairs for CAR T cell treatment of solid tumors.
Sci Rep
February 2022
Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
Many critical advances in research utilize techniques that combine high-resolution with high-content characterization at the single cell level. We introduce the MICS (MACSima Imaging Cyclic Staining) technology, which enables the immunofluorescent imaging of hundreds of protein targets across a single specimen at subcellular resolution. MICS is based on cycles of staining, imaging, and erasure, using photobleaching of fluorescent labels of recombinant antibodies (REAfinity Antibodies), or release of antibodies (REAlease Antibodies) or their labels (REAdye_lease Antibodies).
View Article and Find Full Text PDFHigh Throughput Multi-Omics Approaches for Clinical Trial Evaluation and Drug Discovery.
Front Immunol
July 2021
Hollings Cancer Center, Medical University of South Carolina (MUSC), Charleston, SC, United States.
High throughput single cell multi-omics platforms, such as mass cytometry (cytometry by time-of-flight; CyTOF), high dimensional imaging (>6 marker; Hyperion, MIBIscope, CODEX, MACSima) and the recently evolved genomic cytometry (Citeseq or REAPseq) have enabled unprecedented insights into many biological and clinical questions, such as hematopoiesis, transplantation, cancer, and autoimmunity. In synergy with constantly adapting new single-cell analysis approaches and subsequent accumulating big data collections from these platforms, whole atlases of cell types and cellular and sub-cellular interaction networks are created. These atlases build an ideal scientific discovery environment for reference and data mining approaches, which often times reveals new cellular disease networks.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!